Chiesi Ventures

Glycomine Inc. raised $35M on June 23, 2021

Investors: RiverVest Venture Partners, Remiges Ventures, Inc., Sanofi Ventures, Mission BioCapital, Abingworth, Novo Holdings and Chiesi Ventures

Aura Biosciences raised $80M on March 22, 2021

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Advent Life Sciences, Ysios Capital, Surveyor Capital, Medicxi and Chiesi Ventures

Reneo Pharmaceuticals raised $95M on December 9, 2020

Investors: Aisling Capital, RiverVest Venture Partners, Lundbeckfonden / Lundbeck Foundation, Pappas Capital, Abingworth and Chiesi Ventures

Glycomine Inc. raised $33M on August 7, 2019

Investors: Mission Bay Capital, Sanderling Ventures, Mission BioCapital, Novo Holdings and Chiesi Ventures

Mirum Pharmaceuticals raised $120M on November 7, 2018

Investors: RiverVest Venture Partners, Novo Holdings, Frazier Healthcare Partners, Pappas Capital and Chiesi Ventures

CuraSen Therapeutics, Inc. raised $55M on October 17, 2018

Investors: Pappas Capital, Alta Partners, Tekla Capital Management, Longitude Capital, New Leaf Venture Partners and Chiesi Ventures

VelosBio Inc. raised $58M on October 1, 2018

Investors: Arix Bioscience plc, Pappas Ventures, Sofinnova Ventures, Russia technology fund, Decheng Capital, Takeda UK Limited and Chiesi Ventures

Minoryx Therapeutics raised $25M on September 26, 2018

Investors: SRIW, -, FundPlus, Ysios Capital, Idinvest Partners and Chiesi Ventures

Aura Biosciences raised $30M on December 21, 2017

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Ysios Capital, Advent Life Sciences, LI-COR Biosciences and Chiesi Ventures

Kezar Life Sciences raised $50M on July 25, 2017

Investors: Omega Funds, Bay City Capital, AJU IB INVESTMENT, Qiming Venture Partners, Pappas Ventures, Cowen Inc. and Chiesi Ventures